About: Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.05 (+3.02%)
LABT NASDAQ Lakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics Inc. Common Stock share price
LABT price activity
Last Price
$2.050
Change (24hr)
0.06 USD (3.02%)
Volume
355.01K
Volume (4w avg)
-
Open
$1.99
Day Range
$1.92 - $2.08
Previous Close
$1.99
Last Trade
21 Sep, 8:13 pm GMT+0
Delayed
21 Sep, 8:13 pm GMT+0
LABT price performance
Delayed
21 Sep, 8:13 pm GMT+0
LABT Market Signals